Immatics Biotechnologies Correlations
IMTXW Stock | USD 0.41 0.01 2.38% |
The current 90-days correlation between Immatics Biotechnologies and Eliem Therapeutics is 0.02 (i.e., Significant diversification). The correlation of Immatics Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Immatics Biotechnologies Correlation With Market
Average diversification
The correlation between immatics biotechnologies GmbH and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding immatics biotechnologies GmbH and DJI in the same portfolio, assuming nothing else is changed.
Immatics |
Moving together with Immatics Stock
0.79 | ME | 23Andme Holding | PairCorr |
0.77 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.63 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.73 | MTEM | Molecular Templates | PairCorr |
0.68 | NKTX | Nkarta Inc | PairCorr |
0.72 | TPST | Tempest Therapeutics | PairCorr |
0.71 | AGL | agilon health | PairCorr |
0.61 | EC | Ecopetrol SA ADR | PairCorr |
0.74 | HYMTF | Hyundai Motor | PairCorr |
0.78 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Immatics Stock
0.55 | KZR | Kezar Life Sciences | PairCorr |
0.55 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.46 | MLYS | Mineralys Therapeutics, | PairCorr |
0.79 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
0.77 | BAC | Bank of America Aggressive Push | PairCorr |
0.71 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.67 | KB | KB Financial Group | PairCorr |
0.65 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.64 | HPQ | HP Inc | PairCorr |
0.49 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
0.48 | T | ATT Inc Sell-off Trend | PairCorr |
0.41 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.38 | HD | Home Depot | PairCorr |
0.33 | VFS | VinFast Auto | PairCorr |
Related Correlations Analysis
0.86 | -0.55 | 0.8 | -0.68 | ELYM | ||
0.86 | -0.54 | 0.7 | -0.58 | SCPH | ||
-0.55 | -0.54 | -0.39 | 0.51 | MIST | ||
0.8 | 0.7 | -0.39 | -0.63 | MCRB | ||
-0.68 | -0.58 | 0.51 | -0.63 | LUMO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immatics Stock performing well and Immatics Biotechnologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immatics Biotechnologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ELYM | 3.92 | (0.78) | 0.00 | 0.73 | 0.00 | 6.21 | 34.87 | |||
SCPH | 2.64 | (0.84) | 0.00 | (0.35) | 0.00 | 4.05 | 20.70 | |||
MIST | 1.90 | 0.19 | 0.12 | 0.24 | 1.61 | 7.19 | 18.66 | |||
MCRB | 4.93 | 0.19 | 0.02 | 0.60 | 5.66 | 10.84 | 28.84 | |||
LUMO | 2.44 | 0.38 | 0.06 | (0.43) | 2.72 | 5.95 | 16.25 |
Immatics Biotechnologies Corporate Management
Andrea Mokler | VP Sciences | Profile | |
Miriam Meyer | VP Affairs | Profile | |
Edward Sturchio | General Secretary | Profile | |
Arnd MBA | Chief Officer | Profile | |
Toni Weinschenk | CoFounder Officer | Profile | |
Thomas Ulmer | Chief Officer | Profile |